Boppana S B, Fowler K B, Britt W J, Stagno S, Pass R F
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pediatrics. 1999 Jul;104(1 Pt 1):55-60. doi: 10.1542/peds.104.1.55.
To determine the frequency of symptomatic congenital cytomegalovirus (CMV) infection in the offspring of women with a recurrent maternal CMV infection and to characterize the demographic and newborn findings.
Study subjects consisted of infants with symptomatic congenital CMV infection identified by a newborn virologic screening program at the University of Alabama Hospital between 1991 and 1997 and were enrolled in a long-term follow-up study. Maternal infections were categorized by an analysis of archival serum specimens collected before pregnancy and at the time of delivery. Demographic data and clinical findings at birth were collected from maternal and newborn hospital records and from parents at the time of initial evaluation.
Of the 47 infants with symptomatic congenital CMV infection identified during the study period, 8 were born to mothers with a confirmed nonprimary or recurrent CMV infection. The type of maternal infection could be ascertained in only approximately 43% (20/47) of the children with symptomatic congenital CMV infection born at the University of Alabama Hospital during the study period. There were no significant differences in demographic characteristics of the recurrent infection group and the infants who were born to mothers with either primary CMV infection during pregnancy or unclassified maternal infection. Similarly, the range of severity of clinical abnormalities during the newborn period did not differ in the two groups of children. Furthermore, there were no significant differences in the incidence of sequelae at long-term follow-up in the two groups of children.
Symptomatic congenital CMV infection can occur after a nonprimary or recurrent maternal infection. However, the exact incidence of symptomatic congenital CMV infection among children born to women with preexisting immunity remains to be defined.
确定复发性母体巨细胞病毒(CMV)感染的女性后代中症状性先天性CMV感染的发生率,并描述人口统计学和新生儿检查结果。
研究对象包括1991年至1997年在阿拉巴马大学医院通过新生儿病毒学筛查项目确诊为症状性先天性CMV感染的婴儿,并纳入一项长期随访研究。通过分析妊娠前和分娩时采集的存档血清标本对母体感染进行分类。从母体和新生儿医院记录以及初次评估时的父母处收集出生时的人口统计学数据和临床检查结果。
在研究期间确定的47例症状性先天性CMV感染婴儿中,8例母亲确诊为非原发性或复发性CMV感染。在研究期间于阿拉巴马大学医院出生的有症状性先天性CMV感染的儿童中,仅约43%(20/47)的儿童能够确定母体感染类型。复发性感染组与孕期原发性CMV感染母亲或未分类母体感染母亲所生婴儿的人口统计学特征无显著差异。同样,两组儿童新生儿期临床异常的严重程度范围也无差异。此外,两组儿童长期随访时后遗症的发生率也无显著差异。
非原发性或复发性母体感染后可发生症状性先天性CMV感染。然而,已有免疫力的女性所生儿童中症状性先天性CMV感染的确切发生率仍有待确定。